ArticleCancer science2010

Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer.

Tomomi Egawa-Takata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.